Biblio
Export 34 results:
Author Title Type [ Year
Filters: Author is Scheltens, Philip [Clear All Filters]
“Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.”, J Alzheimers Dis, 2018.
, “Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”, J Alzheimers Dis, 2018.
, “Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?”, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.
, “Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
, “Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
, “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
, “The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
,